Journal list menu
Export Citations
Download PDFs
Issue Information
Reviews
Open Access
oa
Systematic review of sodium-glucose cotransporter 2 inhibitors: a hopeful prospect in tackling heart failure-related events
- Pages: 1499-1530
- First Published: 26 March 2023
Open Access
oa
ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
- Pages: 1531-1544
- First Published: 02 December 2022
Open Access
oa
Structural components for the development of a heart failure network
- Pages: 1545-1554
- First Published: 09 December 2022
Open Access
oa
Are arrhythmias the drivers of sudden cardiac death in heart failure with preserved ejection fraction? A review
- Pages: 1555-1569
- First Published: 09 December 2022
Open Access
oa
Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
- Pages: 1570-1579
- First Published: 13 January 2023
Open Access
oa
Heart failure with reduced ejection fraction and atrial fibrillation: a Sub-Saharan African perspective
- Pages: 1580-1596
- First Published: 19 March 2023
Original Articles
Open Access
oa
Machine learning approach to stratify complex heterogeneity of chronic heart failure: A report from the CHART-2 study
- Pages: 1597-1604
- First Published: 14 February 2023
Open Access
oa
Isolated functional tricuspid regurgitation: how to define patients at risk for event?
- Pages: 1605-1614
- First Published: 21 February 2023
Open Access
oa
The burden of heart failure in cardiac intensive care unit: a prospective 7 years analysis
- Pages: 1615-1622
- First Published: 17 February 2023
Open Access
oa
Real-world safety of neurohormonal antagonist initiation among older adults following a heart failure hospitalization
- Pages: 1623-1634
- First Published: 20 February 2023
Open Access
oa
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure
- Pages: 1635-1642
- First Published: 13 February 2023
Open Access
oa
Diagnostic accuracy of natriuretic peptide screening for left ventricular systolic dysfunction in the community: systematic review and meta-analysis
- Pages: 1643-1655
- First Published: 13 February 2023
Open Access
oa
Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
- Pages: 1656-1665
- First Published: 16 February 2023
Open Access
oa
The short and long-term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy
- Pages: 1666-1676
- First Published: 17 February 2023
Open Access
oa
Polypyrimidine tract binding protein 1 exacerbates cardiac fibrosis by regulating fatty acid-binding protein 5
- Pages: 1677-1688
- First Published: 14 February 2023
Open Access
oa
Functional assessment based on cardiopulmonary exercise testing in mild heart failure: A multicentre study
- Pages: 1689-1697
- First Published: 21 February 2023
Open Access
oa
The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients
- Pages: 1698-1705
- First Published: 23 February 2023
Open Access
oa
Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease
- Pages: 1706-1716
- First Published: 23 February 2023
Open Access
oa
Long-term risk stratification for hospitalized patients with acute heart failure at a single rural cardiovascular centre
- Pages: 1717-1725
- First Published: 25 February 2023
Open Access
oa
Fibrosis-4 index identifies worsening renal function associated with adverse outcomes in acute heart failure
- Pages: 1726-1734
- First Published: 25 February 2023
Open Access
oa
Prognosis evaluation of chronic inflammatory cardiomyopathy with ring-like late gadolinium enhancement
- Pages: 1735-1744
- First Published: 26 February 2023
Open Access
oa
Prevalence of heart failure phenotypes and current use of therapies in primary care: results from a nationwide study
- Pages: 1745-1756
- First Published: 28 February 2023
Open Access
oa
Association between changes in loop diuretic dose and outcomes in acute heart failure
- Pages: 1757-1770
- First Published: 01 March 2023
Open Access
oa
Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction
- Pages: 1771-1780
- First Published: 02 March 2023
Open Access
oa
Long-term cumulative high-sensitivity cardiac troponin T and mortality among patients with acute heart failure
- Pages: 1781-1792
- First Published: 03 March 2023
Open Access
oa
Association between MMP2 gene polymorphisms and dilated cardiomyopathy in a Chinese Han population
- Pages: 1793-1802
- First Published: 03 March 2023
Open Access
oa
Serum angiotensin-converting enzyme levels indicating early sarcoidosis diagnosis and immunosuppressive therapy efficacy
- Pages: 1803-1810
- First Published: 09 March 2023
Open Access
oa
Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension
- Pages: 1811-1821
- First Published: 10 March 2023
Open Access
oa
The impact of heart failure therapy in patients with mildly reduced ejection fraction: a network meta-analysis
- Pages: 1822-1834
- First Published: 10 March 2023
Open Access
oa
Long-term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non-cardiac mortality
- Pages: 1835-1846
- First Published: 10 March 2023
Open Access
oa
Magnetic resonance imaging of organ iron before and after correction of iron deficiency in patients with heart failure
- Pages: 1847-1859
- First Published: 12 March 2023
Open Access
oa
Effects of angiotensin receptor-neprilysin inhibitor on insulin resistance in patients with heart failure
- Pages: 1860-1870
- First Published: 21 March 2023
Open Access
oa
Health-related quality of life among transthyretin amyloid cardiomyopathy patients
- Pages: 1871-1882
- First Published: 22 March 2023
Open Access
oa
Gender-specific prevalence and trend of heart failure in China from 1990 to 2019
- Pages: 1883-1895
- First Published: 26 March 2023
Open Access
oa
Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan
- Pages: 1896-1906
- First Published: 27 March 2023
Open Access
oa
Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor-associated cardiotoxicity
- Pages: 1907-1918
- First Published: 28 March 2023
Open Access
oa
Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care
- Pages: 1919-1927
- First Published: 28 March 2023
Open Access
oa
Association between lactate/albumin ratio and mortality in patients with heart failure after myocardial infarction
- Pages: 1928-1936
- First Published: 28 March 2023
Open Access
oa
Predictive value of global longitudinal strain by left ventricular ejection fraction
- Pages: 1937-1947
- First Published: 29 March 2023
Open Access
oa
Tricuspid regurgitation in elderly patients with acute heart failure: insights from the KCHF registry
- Pages: 1948-1960
- First Published: 29 March 2023
Open Access
oa
Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real-world study
- Pages: 1961-1971
- First Published: 29 March 2023
Open Access
oa
Beta-blocker use and mortality among patients with systolic heart failure and pacemaker rhythm
- Pages: 1972-1979
- First Published: 30 March 2023
Open Access
oa
Pre-operative pulmonary artery pulsatility index does not predict mortality post-cardiac transplantation
- Pages: 1980-1986
- First Published: 31 March 2023
Open Access
oa
Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes
- Pages: 1987-1995
- First Published: 03 April 2023
Open Access
oa
Trends in heart failure prevalence in Japan 2014–2019: a report from healthcare administration databases
- Pages: 1996-2009
- First Published: 05 April 2023
Open Access
oa
Retrospective analysis of SGLT2 inhibitors in heart failure with preserved ejection fraction
- Pages: 2010-2018
- First Published: 11 April 2023
Open Access
oa
Heart failure with preserved ejection fraction phenogroup classification using machine learning
- Pages: 2019-2030
- First Published: 12 April 2023
Open Access
oa
Association between coronary flow and aortic stenosis during transcatheter aortic valve implantation
- Pages: 2031-2041
- First Published: 13 April 2023
Open Access
oa
Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure
- Pages: 2042-2050
- First Published: 13 April 2023
Study Designs
Open Access
oa
Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study
- Pages: 2051-2065
- First Published: 12 March 2023
Open Access
oa
Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN-HF study
- Pages: 2066-2073
- First Published: 15 March 2023
Open Access
oa
Regional management of worsening heart failure: rationale and design of the CHAIN-HF registry
- Pages: 2074-2083
- First Published: 25 March 2023
Case Report
Open Access
oa
Coronary-subclavian steal syndrome causing myocardial infarction after arteriovenous fistula creation: a case report
- Pages: 2084-2089
- First Published: 05 March 2023
Open Access
oa
Acute myocarditis with transient myocardial thickening in two oncologic patients treated with anti-GD2 immunotherapy
- Pages: 2090-2093
- First Published: 07 March 2023
Open Access
oa
HeartMate 3 biventricular support exceeding 4.5 years
- Pages: 2094-2098
- First Published: 10 March 2023
Open Access
oa
Dramatic disease regression in a case of HFrEF with end-stage renal failure treated with sacubitril/valsartan and SGLT2i
- Pages: 2099-2106
- First Published: 12 March 2023
Open Access
oa
Churg–Strauss syndrome-associated heart failure and left ventricular thrombosis
- Pages: 2107-2112
- First Published: 25 March 2023
Short Communications
Open Access
oa
IGFBP7 and left ventricular mass regression: a sub-analysis of the EMPA-HEART CardioLink-6 randomized clinical trial
- Pages: 2113-2119
- First Published: 10 April 2023
Open Access
oa
Is excessive ventricular irregularity predictive of rehospitalization in patients with permanent AF and HFpEF?
- Pages: 2120-2126
- First Published: 20 March 2023
Open Access
oa
Baseline neutrophil-to-lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling
- Pages: 2127-2133
- First Published: 10 April 2023
Open Access
oa
Impact of diabetes duration on left ventricular mass regression with empagliflozin
- Pages: 2134-2140
- First Published: 10 April 2023
Reply
Open Access
oa
Sodium-glucose transporter 2 inhibitors may improve the prognosis of acute heart failure by correcting hypocapnia
- Pages: 2141-2142
- First Published: 18 April 2023
Corrections
Open Access
oa
Correction to: “Heart failure: an update from the last years and a look at the near future” and articles listed below
- Page: 2143
- First Published: 23 March 2023
Open Access
oa
Correction to: ‘Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction’
- Page: 2145
- First Published: 31 March 2023